drugset / Trial / NCT04709705
DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
Phase 2/3
Completed
161 enrolled
Cellphire Therapeutics, Inc.
U.S. Army Medical Research and Development Command · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized, parallel group, active comparator-controlled trial to evaluate the non-inferiority or superiority of Cryopreserved Platelets with Liquid Stored Platelets in controlling blood loss in patients undergoing Cardiopulmonary Bypass Surgery.
Timeline
- Start
- 2021-10-27
- Primary completion
- 2025-05-08
- Completion
- 2025-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human platelets | Unknown | 3 unknown | — |